866-997-4948(US-Canada Toll Free)

United States Oral Vaccines Market Report 2017

Published By :

QYResearch

Published Date : Apr 2017

Category :

Pharmaceutical

No. of Pages : 106 Pages

In this report, the United States Oral Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Oral Vaccines in these regions, from 2012 to 2022 (forecast).

United States Oral Vaccines market competition by top manufacturers/players, with Oral Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
GlaxoSmithKline Plc.
PaxVax Corporation
Merial, Inc.
Merck Sharp & Dohme Corp
VALNEVA Canada Inc.
QUMICA SUIZA S.A
Immunitor, Inc
Aventis (Sanofi S.A.)
Serum Institute of India Pvt. Ltd
Swiss Serum and Vaccine Institute Berne
Bull Bio - NCIPD Ltd.
Vaxart, Inc.
Shantha Biotechnics
Crucell (Janssen Global Services, LLC)

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Live Attenuated Vaccines
Killed/Inactivated Vaccines
Recombinant Vaccines
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Oral Vaccines for each application, including
Polio
Rabies
Rotavirus
Cholera
HIV
Respiratory Infections
Influenza
Tuberculosis
Others

Table of Contents

United States Oral Vaccines Market Report 2017
1 Oral Vaccines Overview
1.1 Product Overview and Scope of Oral Vaccines
1.2 Classification of Oral Vaccines by Product Category
1.2.1 United States Oral Vaccines Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Oral Vaccines Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Live Attenuated Vaccines
1.2.4 Killed/Inactivated Vaccines
1.2.5 Recombinant Vaccines
1.2.6 Others
1.3 United States Oral Vaccines Market by Application/End Users
1.3.1 United States Oral Vaccines Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Polio
1.3.3 Rabies
1.3.4 Rotavirus
1.3.5 Cholera
1.3.6 HIV
1.3.7 Respiratory Infections
1.3.8 Influenza
1.3.9 Tuberculosis
1.3.10 Others
1.4 United States Oral Vaccines Market by Region
1.4.1 United States Oral Vaccines Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Oral Vaccines Status and Prospect (2012-2022)
1.4.3 Southwest Oral Vaccines Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Oral Vaccines Status and Prospect (2012-2022)
1.4.5 New England Oral Vaccines Status and Prospect (2012-2022)
1.4.6 The South Oral Vaccines Status and Prospect (2012-2022)
1.4.7 The Midwest Oral Vaccines Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Oral Vaccines (2012-2022)
1.5.1 United States Oral Vaccines Sales and Growth Rate (2012-2022)
1.5.2 United States Oral Vaccines Revenue and Growth Rate (2012-2022)

2 United States Oral Vaccines Market Competition by Players/Suppliers
2.1 United States Oral Vaccines Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Oral Vaccines Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Oral Vaccines Average Price by Players/Suppliers (2012-2017)
2.4 United States Oral Vaccines Market Competitive Situation and Trends
2.4.1 United States Oral Vaccines Market Concentration Rate
2.4.2 United States Oral Vaccines Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Oral Vaccines Manufacturing Base Distribution, Sales Area, Product Type

3 United States Oral Vaccines Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Oral Vaccines Sales and Market Share by Region (2012-2017)
3.2 United States Oral Vaccines Revenue and Market Share by Region (2012-2017)
3.3 United States Oral Vaccines Price by Region (2012-2017)

4 United States Oral Vaccines Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Oral Vaccines Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Oral Vaccines Revenue and Market Share by Type (2012-2017)
4.3 United States Oral Vaccines Price by Type (2012-2017)
4.4 United States Oral Vaccines Sales Growth Rate by Type (2012-2017)

5 United States Oral Vaccines Sales (Volume) by Application (2012-2017)
5.1 United States Oral Vaccines Sales and Market Share by Application (2012-2017)
5.2 United States Oral Vaccines Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Oral Vaccines Players/Suppliers Profiles and Sales Data
6.1 GlaxoSmithKline Plc.
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Oral Vaccines Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 GlaxoSmithKline Plc. Oral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 PaxVax Corporation
6.2.2 Oral Vaccines Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 PaxVax Corporation Oral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Merial, Inc.
6.3.2 Oral Vaccines Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Merial, Inc. Oral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Merck Sharp & Dohme Corp
6.4.2 Oral Vaccines Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Merck Sharp & Dohme Corp Oral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 VALNEVA Canada Inc.
6.5.2 Oral Vaccines Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 VALNEVA Canada Inc. Oral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 QUMICA SUIZA S.A
6.6.2 Oral Vaccines Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 QUMICA SUIZA S.A Oral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Immunitor, Inc
6.7.2 Oral Vaccines Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Immunitor, Inc Oral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Aventis (Sanofi S.A.)
6.8.2 Oral Vaccines Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Aventis (Sanofi S.A.) Oral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Serum Institute of India Pvt. Ltd
6.9.2 Oral Vaccines Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Serum Institute of India Pvt. Ltd Oral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Swiss Serum and Vaccine Institute Berne
6.10.2 Oral Vaccines Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Swiss Serum and Vaccine Institute Berne Oral Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Bull Bio - NCIPD Ltd.
6.12 Vaxart, Inc.
6.13 Shantha Biotechnics
6.14 Crucell (Janssen Global Services, LLC)

7 Oral Vaccines Manufacturing Cost Analysis
7.1 Oral Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Oral Vaccines

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Oral Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Oral Vaccines Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Oral Vaccines Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Oral Vaccines Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Oral Vaccines Sales Volume Forecast by Type (2017-2022)
11.3 United States Oral Vaccines Sales Volume Forecast by Application (2017-2022)
11.4 United States Oral Vaccines Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Oral Vaccines
Figure United States Oral Vaccines Market Size (K Pcs) by Type (2012-2022)
Figure United States Oral Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure Live Attenuated Vaccines Product Picture
Figure Killed/Inactivated Vaccines Product Picture
Figure Recombinant Vaccines Product Picture
Figure Others Product Picture
Figure United States Oral Vaccines Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Oral Vaccines by Application in 2016
Figure Polio Examples
Figure Rabies Examples
Figure Rotavirus Examples
Figure Cholera Examples
Figure HIV Examples
Figure Respiratory Infections Examples
Figure Influenza Examples
Figure Tuberculosis Examples
Figure Others Examples
Figure United States Oral Vaccines Market Size (Million USD) by Region (2012-2022)
Figure The West Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Oral Vaccines Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Oral Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Oral Vaccines Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Oral Vaccines Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Oral Vaccines Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Oral Vaccines Sales Share by Players/Suppliers
Figure 2017 United States Oral Vaccines Sales Share by Players/Suppliers
Figure United States Oral Vaccines Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Oral Vaccines Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Oral Vaccines Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Oral Vaccines Revenue Share by Players/Suppliers
Figure 2017 United States Oral Vaccines Revenue Share by Players/Suppliers
Table United States Market Oral Vaccines Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Oral Vaccines Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Oral Vaccines Market Share of Top 3 Players/Suppliers
Figure United States Oral Vaccines Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Oral Vaccines Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Oral Vaccines Product Category
Table United States Oral Vaccines Sales (K Pcs) by Region (2012-2017)
Table United States Oral Vaccines Sales Share by Region (2012-2017)
Figure United States Oral Vaccines Sales Share by Region (2012-2017)
Figure United States Oral Vaccines Sales Market Share by Region in 2016
Table United States Oral Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Oral Vaccines Revenue Share by Region (2012-2017)
Figure United States Oral Vaccines Revenue Market Share by Region (2012-2017)
Figure United States Oral Vaccines Revenue Market Share by Region in 2016
Table United States Oral Vaccines Price (USD/Pcs) by Region (2012-2017)
Table United States Oral Vaccines Sales (K Pcs) by Type (2012-2017)
Table United States Oral Vaccines Sales Share by Type (2012-2017)
Figure United States Oral Vaccines Sales Share by Type (2012-2017)
Figure United States Oral Vaccines Sales Market Share by Type in 2016
Table United States Oral Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Oral Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oral Vaccines by Type (2012-2017)
Figure Revenue Market Share of Oral Vaccines by Type in 2016
Table United States Oral Vaccines Price (USD/Pcs) by Types (2012-2017)
Figure United States Oral Vaccines Sales Growth Rate by Type (2012-2017)
Table United States Oral Vaccines Sales (K Pcs) by Application (2012-2017)
Table United States Oral Vaccines Sales Market Share by Application (2012-2017)
Figure United States Oral Vaccines Sales Market Share by Application (2012-2017)
Figure United States Oral Vaccines Sales Market Share by Application in 2016
Table United States Oral Vaccines Sales Growth Rate by Application (2012-2017)
Figure United States Oral Vaccines Sales Growth Rate by Application (2012-2017)
Table GlaxoSmithKline Plc. Basic Information List
Table GlaxoSmithKline Plc. Oral Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc. Oral Vaccines Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Plc. Oral Vaccines Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Plc. Oral Vaccines Revenue Market Share in United States (2012-2017)
Table PaxVax Corporation Basic Information List
Table PaxVax Corporation Oral Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure PaxVax Corporation Oral Vaccines Sales Growth Rate (2012-2017)
Figure PaxVax Corporation Oral Vaccines Sales Market Share in United States (2012-2017)
Figure PaxVax Corporation Oral Vaccines Revenue Market Share in United States (2012-2017)
Table Merial, Inc. Basic Information List
Table Merial, Inc. Oral Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merial, Inc. Oral Vaccines Sales Growth Rate (2012-2017)
Figure Merial, Inc. Oral Vaccines Sales Market Share in United States (2012-2017)
Figure Merial, Inc. Oral Vaccines Revenue Market Share in United States (2012-2017)
Table Merck Sharp & Dohme Corp Basic Information List
Table Merck Sharp & Dohme Corp Oral Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck Sharp & Dohme Corp Oral Vaccines Sales Growth Rate (2012-2017)
Figure Merck Sharp & Dohme Corp Oral Vaccines Sales Market Share in United States (2012-2017)
Figure Merck Sharp & Dohme Corp Oral Vaccines Revenue Market Share in United States (2012-2017)
Table VALNEVA Canada Inc. Basic Information List
Table VALNEVA Canada Inc. Oral Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure VALNEVA Canada Inc. Oral Vaccines Sales Growth Rate (2012-2017)
Figure VALNEVA Canada Inc. Oral Vaccines Sales Market Share in United States (2012-2017)
Figure VALNEVA Canada Inc. Oral Vaccines Revenue Market Share in United States (2012-2017)
Table QUMICA SUIZA S.A Basic Information List
Table QUMICA SUIZA S.A Oral Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure QUMICA SUIZA S.A Oral Vaccines Sales Growth Rate (2012-2017)
Figure QUMICA SUIZA S.A Oral Vaccines Sales Market Share in United States (2012-2017)
Figure QUMICA SUIZA S.A Oral Vaccines Revenue Market Share in United States (2012-2017)
Table Immunitor, Inc Basic Information List
Table Immunitor, Inc Oral Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Immunitor, Inc Oral Vaccines Sales Growth Rate (2012-2017)
Figure Immunitor, Inc Oral Vaccines Sales Market Share in United States (2012-2017)
Figure Immunitor, Inc Oral Vaccines Revenue Market Share in United States (2012-2017)
Table Aventis (Sanofi S.A.) Basic Information List
Table Aventis (Sanofi S.A.) Oral Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Aventis (Sanofi S.A.) Oral Vaccines Sales Growth Rate (2012-2017)
Figure Aventis (Sanofi S.A.) Oral Vaccines Sales Market Share in United States (2012-2017)
Figure Aventis (Sanofi S.A.) Oral Vaccines Revenue Market Share in United States (2012-2017)
Table Serum Institute of India Pvt. Ltd Basic Information List
Table Serum Institute of India Pvt. Ltd Oral Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Serum Institute of India Pvt. Ltd Oral Vaccines Sales Growth Rate (2012-2017)
Figure Serum Institute of India Pvt. Ltd Oral Vaccines Sales Market Share in United States (2012-2017)
Figure Serum Institute of India Pvt. Ltd Oral Vaccines Revenue Market Share in United States (2012-2017)
Table Swiss Serum and Vaccine Institute Berne Basic Information List
Table Swiss Serum and Vaccine Institute Berne Oral Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Swiss Serum and Vaccine Institute Berne Oral Vaccines Sales Growth Rate (2012-2017)
Figure Swiss Serum and Vaccine Institute Berne Oral Vaccines Sales Market Share in United States (2012-2017)
Figure Swiss Serum and Vaccine Institute Berne Oral Vaccines Revenue Market Share in United States (2012-2017)
Table Bull Bio - NCIPD Ltd. Basic Information List
Table Vaxart, Inc. Basic Information List
Table Shantha Biotechnics Basic Information List
Table Crucell (Janssen Global Services, LLC) Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oral Vaccines
Figure Manufacturing Process Analysis of Oral Vaccines
Figure Oral Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Oral Vaccines Major Players/Suppliers in 2016
Table Major Buyers of Oral Vaccines
Table Distributors/Traders List
Figure United States Oral Vaccines Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Oral Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Oral Vaccines Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Oral Vaccines Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Oral Vaccines Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Oral Vaccines Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Oral Vaccines Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Oral Vaccines Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Oral Vaccines Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Oral Vaccines Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Oral Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Oral Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Oral Vaccines Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *